Myasthenia gravis is an autoimmune neuromuscular disease causing fluctuating muscle weakness, typically worsening with activity. Antibodies against acetylcholine receptors at the neuromuscular junction impair signal transmission; treatment includes cholinesterase inhibitors and immunosuppressants.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: